The establishment of evaluating method for general fatigue and the investigation of Kampo-medicine, Jyu-zen-ho-eki-tou, on general fatigue induced by cisplatin

The establishment of evaluating method for general fatigue and the investigation of Kampo-medicine, Jyu-zen-ho-eki-tou, on general fatigue induced by cisplatin - Cisplatin-induced general fatigue and Kampo-medicine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015799

Enrollment

Registered

2015-01-01

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological patients with urothelial carcinoma, who will receive chemotherapy using cisplatin

Interventions

Jyu-zen-dai-ho-tou, 7.5g/day, p.o. contorol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1Urothelial carcinoma patients who will receive chemotherapy with cisplatine

Exclusion criteria

Exclusion criteria: Patients who did not agree with this trial

Design outcomes

Primary

Measure	Time frame
Cancer fatigue scale	—

Secondary

Measure	Time frame
Background of patinets (height, body weight, past history, drug, Hie-shou), Visual analogue scale of general fatigue and Hie-shou, achievement rate of chemotherapy, adverse event of chemotherapy, renal function, anti-cancer effect	—

Countries

Japan

Contacts

Public ContactTomonori Minagawa

Shinshu University Hospital Urology

minagawat@shinshu-u.ac.jp0263-37-2661

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026